Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer

IMPORTANCE: Immunotherapy is now a cornerstone of treatment for advanced non–small cell lung cancer (NSCLC), but its uptake and effectiveness among older patients outside clinical trials remain poorly understood. OBJECTIVE: To understand treatment patterns and evaluate the overall survival associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kehl, Kenneth L., Greenwald, Scott, Chamoun, Nassib G., Manberg, Paul J., Schrag, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140374/
https://www.ncbi.nlm.nih.gov/pubmed/34019086
http://dx.doi.org/10.1001/jamanetworkopen.2021.11113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140374/
https://www.ncbi.nlm.nih.gov/pubmed/34019086
http://dx.doi.org/10.1001/jamanetworkopen.2021.11113

Ejemplares similares